IRCT201211062883N3Completed未知
Evaluation of cardioprotective effects of N-acetylcysteine” to cardioplegia and glucose-insulin-potassium” during coronary artery bypass grafting in patient candidate for CABG
Mazandaran Uiversity of Medical Sciences and Health Services0 sites60 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 35 years to 75 years (—)
- Sex
- All
Inclusion Criteria
- •patients who candidate for CABG with EF below 50% at Mazandaran Heart Center
- •Exclusion critera:Valvular heart diseases; renal failure; liver disease; cross clamp time more than 1:30 min & use of intraaotric baloon pomp
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Phase 3
Evaluation of the effects of the cardioprotective diet on prevention of the incidence of cardiotoxicitycardiotoxicity in patients with breast cancer receiving Anthracycline.Malignant NeoplasmsC00-C97IRCT20131218015860N7School of Traditional Medicine, Traditional Medicine and Materia Medica Research Center,Shahid Behes60
Recruiting
Unknown
Verification of the cardioprotective effect of ARNI on hemodialysis patients with heart diseaseHemodialysis patients with chronic heart failureJPRN-UMIN000052905Inoue Hospital300
Completed
Phase 2
Evaluation of the protective effect of N-Acetyle-Cysteine versus placebo on the heart of diabetic patients undergoing CABGCoronary artery bypass graft.Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectorisI25.70IRCT20120215009014N202Hamedan University of Medical Sciences240
Completed
Phase 3
Investigating the efficacy and safety of N-Acetyl Cysteine (NAC) inhalation spray in controlling the symptoms of patients with COVID-19IRCT20080901001165N55Bagheiat-allah University of Medical Sciences250
Recruiting
Phase 4
Effects of N-acetylcysteine on cardiovascular parameters in thalassemia major patientsThalassemia majorHRV parametersMagnetic resonance acquisitionN-acetylcysteine (NAC) therapyTCTR20160725002The Faculty of Medicine Endowment fund100